US 9181220
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
granted A61PA61P3/06A61P3/10
Quick answer
US patent 9181220 (N-substituted-heterocycloalkyloxybenzamide compounds and methods of use) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P3/06, A61P3/10, A61P43/00, A61P9/00